Verified · Documented · Trusted

Age & Research Use Verification

Please confirm both statements to continue.

Exit Site

By entering, you agree to our Terms of Service and Privacy Policy. This site sells laboratory reagents strictly for in-vitro research use only, not for human or veterinary consumption.

Skip to content
Free UPS Ground $150+ · Free 2nd Day Air $200+
All Articles Shop Products

// Research Library

Sermorelin vs Tesamorelin: Comparing Two GHRH Analogs for Laboratory Research

·Genetic Peptides USA

Sermorelin and tesamorelin are both synthetic analogs of human growth hormone-releasing hormone (GHRH, also called GRF or somatoliberin). In a research catalog they are easy to confuse, because they share the same N-terminal amino acid stretch and they are both used as GHRH receptor (GHRHR) ligands. They are not the same chemical entity. The chain lengths, N-terminal chemistry, molecular formulas, masses, and CAS numbers are different, and a certificate of analysis (COA) that is correct for one lot label is wrong for the other.

This page is a laboratory identity guide. It compares the two structures, shows what should appear on a lot COA, and points to the existing compound overviews and product pages. It is not a use protocol.

Sermorelin and tesamorelin research materials are for research use only. They are not for human or veterinary use. This article does not describe protocols, amounts, or any in-life application.

How both analogs relate to native GHRH

Native human GHRH is a 44-amino-acid peptide. Residues 1-29 of that sequence are the portion most often discussed in receptor-ligand research, and those 29 residues are the shared backbone of the two analogs covered here.

Sermorelin stops at residue 29 and is supplied as the C-terminal amide, usually written GHRH(1-29)-NH2 or GRF(1-29) amide. Tesamorelin keeps the full 44-residue GHRH sequence, adds a trans-3-hexenoyl (hex-3-enoyl) group on the N-terminal tyrosine, and is also C-terminally amidated. In short: one analog is the amidated 29-residue sequence, and the other is a 44-residue, N-hexenoyl GHRH analog.

That shared 1-29 stretch is why the two names appear together in search queries and lab notes. It is also why identity checks have to go beyond the word "GHRH analog" on a label.

What sermorelin is

Sermorelin is the C-terminally amidated 29-residue peptide that matches residues 1-29 of human GHRH.

  • One-letter sequence: YADAIFTNSYRKVLGQLSARKLLQDIMSR-NH2
  • Molecular formula: C149H246N44O42S
  • Average molecular mass: about 3357.9 Da
  • CAS number (free peptide): 86168-78-7
  • Related CAS number (acetate salt): 114466-38-5

These identifiers are the values listed in PubChem for sermorelin (CID 16132413). Research lots are often prepared as acetate salts. When you compare a calculated mass to a measured mass on a COA, the salt form and the net peptide content both matter. Purity by HPLC is a separate measurement from peptide content.

A longer compound-level summary is in the Sermorelin Research Peptide Overview. The corresponding catalog item is Sermorelin 10mg.

What tesamorelin is

Tesamorelin, also recorded under the development code TH9507, is a 44-residue analog of human GHRH(1-44). Two covalent features define the structure: a trans-3-hexenoyl group on Tyr1, and a C-terminal leucine amide.

  • One-letter peptide sequence (without the hexenoyl group written out): YADAIFTNSYRKVLGQLSARKLLQDIMSRQQGESNQERGARARL-NH2
  • N-terminal modification: (3E)-hex-3-enoyl on Tyr1
  • Molecular formula: C221H366N72O67S
  • Average molecular mass: about 5136 Da
  • CAS number: 218949-48-5

These identifiers appear in the USAN record for tesamorelin, in ChEBI (CHEBI:63626), and in PubChem (CID 16137828).

The first 29 amino acids of tesamorelin are the same residues as sermorelin. Residues 30-44 (QQGESNQERGARARL) and the N-terminal hexenoyl group are what make tesamorelin a different compound, with a substantially higher mass.

See the Tesamorelin Research Peptide Overview and the Tesamorelin research product page for lot documentation on the catalog item.

Side-by-side comparison

Feature Sermorelin Tesamorelin
Relationship to human GHRH Residues 1-29, C-terminal amide Residues 1-44, N-terminal trans-3-hexenoyl, C-terminal amide
Residue count 29 44
N-terminal chemistry Free Tyr1 (no hexenoyl group) (3E)-hex-3-enoyl on Tyr1
C-terminus Arginine amide Leucine amide
Molecular formula C149H246N44O42S C221H366N72O67S
Average mass About 3357.9 Da About 5136 Da
CAS (free peptide) 86168-78-7 218949-48-5
Common research salt Often acetate (related CAS 114466-38-5) Confirm salt form on the lot COA
Shared sequence YADAIFTNSYRKVLGQLSARKLLQDIMSR Same 1-29 stretch, then QQGESNQERGARARL

The mass gap is about 1,778 Da. That difference is large enough that a correctly assigned intact-mass measurement should not be ambiguous, provided the tesamorelin calculation includes the hexenoyl group.

Why the difference matters for laboratory identity

Because both peptides present the same 1-29 GHRH sequence, they are often grouped as GHRHR research ligands. They are not interchangeable reference standards. A mass, HPLC method, or CAS number that is correct for sermorelin does not describe tesamorelin, and the reverse is also true.

For documentation and receiving checks, four points follow from the structures:

  1. Identity is mass- and sequence-specific. If a tesamorelin COA reports a mass near 3358 Da, the certificate is not describing tesamorelin. If a sermorelin COA reports a mass near 5136 Da, the certificate is not describing sermorelin.
  2. The hexenoyl modification has to be part of the stated tesamorelin structure and of the intact-mass calculation. A COA that lists only unmodified 44-residue GHRH does not describe tesamorelin.
  3. Residues 30-44 are part of tesamorelin's covalent structure. A 29-residue peptide cannot be relabeled as tesamorelin.
  4. Salt form and residual counterion still affect net peptide content for both compounds. A high HPLC purity value does not, by itself, confirm which analog is in the vial.

Other GHRH-axis research tools exist in the same catalog, including CJC-1295 no DAC (modified GRF 1-29). That analog also uses a 29-residue GHRH-related chain, but it is defined by residue substitutions rather than by a 44-residue hexenoyl design. It is a third chemical entity, not a synonym for sermorelin or tesamorelin. A broader map of analog classes is in the published article Research Peptide Classes Explained.

What to confirm on a COA

When a lot is labeled sermorelin or tesamorelin, the certificate should let you check the identity claims, not only a purity percent. At minimum, look for:

  • The stated sequence or modification, including the C-terminal amide for both compounds and the trans-3-hexenoyl group for tesamorelin.
  • A CAS number that matches the intended compound (86168-78-7, or the acetate CAS, for sermorelin; 218949-48-5 for tesamorelin).
  • An observed mass consistent with the formula, including the hexenoyl group when the label is tesamorelin.
  • HPLC purity for that lot, ideally with the chromatogram attached.
  • A lot or batch number that matches the vial label.
  • A clear statement of whether the certificate is batch-specific or only representative.

A full walk-through of certificate fields is in How to Read a Peptide Certificate of Analysis. That process is the right place to resolve a mismatch between a label, a mass, and a CAS number before the material is logged into a study.

Related comparisons that are not this one

Laboratory notes sometimes place sermorelin or tesamorelin next to growth-hormone secretagogues such as ipamorelin or hexarelin, or next to other GHRH analogs such as CJC-1295 no DAC. Those are useful comparisons, but they are not the same as sermorelin versus tesamorelin.

  • Sermorelin and tesamorelin are both GHRH-sequence analogs and GHRHR ligands.
  • Ipamorelin and hexarelin are ghrelin-receptor (GHSR) research ligands. They are not GHRH sequence analogs.
  • CJC-1295 no DAC keeps a 29-residue GHRH-related chain with a different substitution pattern. It is not tesamorelin, and it is not a 44-residue hexenoyl analog.

A tesamorelin comparison against a CJC-1295 and ipamorelin pairing is already published on this blog as CJC-1295/Ipamorelin vs Tesamorelin for GH-Axis Research. This article stays on the narrower identity question: sermorelin versus tesamorelin.

FAQ

Are sermorelin and tesamorelin the same peptide?

No. They share residues 1-29 of human GHRH, but tesamorelin is a 44-residue, N-hexenoyl analog. The two compounds have different formulas, different average masses, and different CAS numbers.

Which CAS number should appear on a sermorelin COA?

The free peptide is CAS 86168-78-7. Acetate lots may also list 114466-38-5. The certificate should state the salt form clearly so the mass and the CAS listing can be read together.

Why does tesamorelin have a higher mass?

The additional 15 amino acids (residues 30-44) and the trans-3-hexenoyl group raise the average formula mass to about 5136 Da, compared with about 3357.9 Da for sermorelin. A correct tesamorelin mass assignment includes both of those contributions.

Can HPLC purity alone tell the two compounds apart?

No. HPLC purity is a lot-quality measurement, not a complete identity test. Retention time can differ between methods and columns. Identity should be confirmed with mass and with the stated sequence or modification, not with a purity percent alone.

Are these catalog materials for human use?

No. The research materials discussed here are for research use only. They are not for human or veterinary use. This page does not provide use instructions.

Sources

  • PubChem Compound Summary, CID 16132413, Sermorelin.
  • PubChem Compound Summary, CID 16137828, Tesamorelin.
  • ChEBI, CHEBI:63626, tesamorelin.
  • USAN Council statement on tesamorelin (CAS 218949-48-5; code designation TH9507).
  • Ferdinandi ES, Brazeau P, High KA, Procter BG, Fennell S, Dubreuil P. Non-Clinical Pharmacology and Safety Evaluation of TH9507, a Human Growth Hormone-Releasing Factor Analogue. Basic Clin Pharmacol Toxicol. 2007;100(1):49-58.

Research use only. Not for human or veterinary use.

COAGHRHResearch GuideSermorelinTesamorelin

// Third-Party Verified

Browse the Research Catalog

Independently third-party tested compounds, 99%+ purity on tested lots. Certificates of analysis are published on the product pages that carry them.

View All Products

More From the Research Library

11 NOV 2026
TB-500 Research Peptide Overview: Synthetic Thymosin Beta-4 and COA Checks
11 NOV 2026
TB-500 and Thymosin Beta-4: CAS Number and Mass on a COA
11 NOV 2026
CJC-1295 + Ipamorelin Blend: Research Overview of a GHRH Analog and GHS Pairing

All products are for in-vitro laboratory research use only. Not for human or animal consumption. This article is provided for informational purposes to a research audience and is not medical advice. Questions? Support@GeneticPeptidesUSA.com

🧬 Ask AI
🧬
GPUSA Research Assistant
Online
Hi! I'm the Genetic Peptides USA research assistant. I can help with questions about our products, pricing, shipping and orders. What can I help you with?
For research purposes only · Not medical advice